Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
M. Shaukat (Heidelberg, Germany), M. Lankeit (Berlin, Germany), D. Cao (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), E. Grünig (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany). Genetic findings in a family with hereditary spherocytosis, haemolytic anaemia and pulmonary hypertension. 596

Member's Comments

No comment yet.

Related content which might interest you: Should we screen for hereditary pulmonary hypertension? Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020 Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020 Year: 2021 Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2004; 23: 373-377 Year: 2004 Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome Source: Eur Respir J 2003 Oct 01;22(4):709-711 Year: 2003 Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019 Year: 2020 A rare diagnosis: Hermansky-Pudlak syndrome in a patient with pulmonary fibrosis, oculocutaneous albinism and thrombocytopathy Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 The pulmonary vascular complications of hereditary haemorrhagic telangiectasia Source: Eur Respir J 2009; 33: 1186-1194 Year: 2009 High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Genetic epidemiology of hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformation Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Autoimmune polyglandular syndrome and pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 657 Year: 2006 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Iron deficiency is common in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 1386-1391 Year: 2011 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Inherited thrombophilia in the development of thrombotic conditions in patients with COPD Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021 Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016